Literature DB >> 23371513

Bioresponsive deciduous-charge amphiphiles for liposomal delivery of DNA and siRNA.

Philippe Pierrat1, Dimitri Kereselidze, Patrick Wehrung, Guy Zuber, Françoise Pons, Luc Lebeau.   

Abstract

PURPOSE: Biolabile cationic lipids were developed for efficient intracellular delivery of DNA and siRNA.
METHODS: The compounds have been designed starting from the membrane lipid DOPC in a way they may loose their cationic charge when exposed to an acidic and/or enzymatic stimulus, such as those met during the journey of a lipoplex in biological media.
RESULTS: They demonstrated remarkable efficiency to deliver DNA in various cell lines (BHK-21, Calu-3, NCI-H292, and A549), with no significant cytotoxicity. Furthermore, two of the compounds (carbonate-based DOPC derivatives) revealed able to deliver small interfering RNA in U87Luc and A549Luc cancer cells and to mediate a selective 70-80% knockdown of the stably transfected luciferase gene.
CONCLUSIONS: The results show that the described bioresponsive cationic lipids have high DNA and siARN delivery activity which is encouraging in view of delivering a therapeutic nucleic acid to pulmonary tissues in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371513     DOI: 10.1007/s11095-013-0976-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  38 in total

1.  Physical and biological properties of cationic triesters of phosphatidylcholine.

Authors:  R C MacDonald; G W Ashley; M M Shida; V A Rakhmanova; Y S Tarahovsky; D P Pantazatos; M T Kennedy; E V Pozharski; K A Baker; R D Jones; H S Rosenzweig; K L Choi; R Qiu; T J McIntosh
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  High efficiency transformation by direct microinjection of DNA into cultured mammalian cells.

Authors:  M R Capecchi
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

3.  Phospholipid-detergent conjugates as novel tools for siRNA delivery.

Authors:  Philippe Pierrat; Gilles Laverny; Gaëlle Creusat; Patrick Wehrung; Jean-Marc Strub; Alain VanDorsselaer; Françoise Pons; Guy Zuber; Luc Lebeau
Journal:  Chemistry       Date:  2013-01-07       Impact factor: 5.236

4.  Manufacture of liposomes by isopropanol injection: characterization of the method.

Authors:  Philippe Gentine; Aurélie Bubel; Corinne Crucifix; Line Bourel-Bonnet; Benoît Frisch
Journal:  J Liposome Res       Date:  2011-06-24       Impact factor: 3.648

5.  O-ethylphosphatidylcholine: A metabolizable cationic phospholipid which is a serum-compatible DNA transfection agent.

Authors:  R C MacDonald; V A Rakhmanova; K L Choi; H S Rosenzweig; M K Lahiri
Journal:  J Pharm Sci       Date:  1999-09       Impact factor: 3.534

6.  Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins.

Authors:  J Rosenecker; S Naundorf; S W Gersting; R W Hauck; A Gessner; P Nicklaus; R H Müller; C Rudolph
Journal:  J Gene Med       Date:  2003-01       Impact factor: 4.565

7.  A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies.

Authors:  K Heeg; J Reimann; D Kabelitz; C Hardt; H Wagner
Journal:  J Immunol Methods       Date:  1985-03-18       Impact factor: 2.303

8.  Bioreversible derivatives of phenol. 2. Reactivity of carbonate esters with fatty acid-like structures towards hydrolysis in aqueous solutions.

Authors:  Jesper Østergaard; Claus Larsen
Journal:  Molecules       Date:  2007-10-30       Impact factor: 4.411

9.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle.

Authors:  E Wagner; C Plank; K Zatloukal; M Cotten; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

10.  A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery.

Authors:  James J Lu; Robert Langer; Jianzhu Chen
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.